Teng Li

Title: Teng Li: Innovator in Cancer Treatment and Multimedia Presentation

Introduction

Teng Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the fields of cancer treatment and multimedia technology. With a total of 2 patents, his work reflects a commitment to innovation and improvement in these critical areas.

Latest Patents

Teng Li's latest patents include a synthetic pathway to belzutifan and crystalline phases of synthetic intermediates. This patent provides crystalline forms for certain synthetic intermediates used in the production of belzutifan, a HIF-2α inhibitor that is beneficial for cancer treatment. The disclosure also outlines processes for isolating these crystalline forms. Another notable patent is a method and system for personalized presentation of multimedia content assembly. This invention offers a method for presenting multimedia content in a personalized manner, allowing for a tailored user experience based on signaling information regarding presentation layer layouts.

Career Highlights

Throughout his career, Teng Li has worked with reputable companies such as Merck Sharp & Dohme Corp. and Werthenstein Biopharma GmbH. His experience in these organizations has contributed to his expertise in both pharmaceutical development and multimedia technology.

Collaborations

Teng Li has collaborated with notable coworkers, including Haiheng Guo and Zhiwei Chen. These partnerships have likely enhanced his innovative capabilities and broadened the impact of his inventions.

Conclusion

Teng Li's contributions to cancer treatment and multimedia presentation demonstrate his innovative spirit and dedication to improving technology for better user experiences and health outcomes. His work continues to influence these fields significantly.